Monday July 8, 2024 6:30pm - 8:30pm Boston Mariott Burlington
Join Us for an Exclusive Event: "Optimizing Dosing in Oncology - The New Paradigm"
Since 2023, the FDA mandates have reshaped the dose optimization landscape in oncology, but new challenges emerge with oral dosing:
π« 50% of Study Participants Deviate from Prescribed Dosing β οΈ 40% of Exposure Data is Unreliable π Drug Efficacy Underestimated, Safety Distorted
The stakes are high:
π Poor Trial Results β³ Delays or Denial of Regulatory Approval πΈ Non or Partial Reimbursement for Off-Label Use
Join the WestRock, AARDEX Group to explore innovative solutions and strategies to tackle these critical issues.Β
Let’s revolutionize drug exposure in clinical trials together!
